Gene expression correlates of neurofibrillary tangles in Alzheimer's disease

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

Design of Experiments

Fisher, R. A. (1936) · BMJ · doi:10.1136/bmj.1.3923.554-a · Cited by 4,980 · see citing works

Randomization and Monte Carlo Methods in Biology.

Foutz, R. V., & Manly, B. F. J. (1992) · Journal of the American Statistical Association · doi:10.2307/2290299 · Cited by 1,627 · see citing works

Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer’s disease

Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B., Mandelkow, E.-M., & Mandelkow, E. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.3.777 · Cited by 820 · see citing works

Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome

Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H., & LaFerla, F. M. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.003 · Cited by 780 · see citing works

Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons

Cáceres, A., & Kosik, K. S. (1990) · Nature · doi:10.1038/343461a0 · Cited by 656 · see citing works

Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway

Li, Y., Liu, L., Barger, S. W., & Griffin, W. S. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01605.2003 · Cited by 563 · see citing works

The calpain family and human disease

Huang, Y., & Wang, K. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02049-4 · Cited by 474 · see citing works

Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease

DeMattos, R. B., O'dell, M. A., Parsadanian, M., Taylor, J. W., Harmony, J. A. K., Bales, K. R., Paul, S. M., Aronow, B. J., & Holtzman, D. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162228299 · Cited by 359 · see citing works

Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1–40).

Backstrom, J. R., Lim, G. P., Cullen, M. J., & Tökés, Z. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-24-07910.1996 · Cited by 331 · cited 1× · see citing works

Overexpression of tau in a nonneuronal cell induces long cellular processes.

Knops, J., Kosik, K. S., Lee, G., Pardee, J. D., Cohen-Gould, L., & McConlogue, L. (1991) · The Journal of cell biology · doi:10.1083/jcb.114.4.725 · Cited by 286 · see citing works

Abnormal TNF activity in Timp3−/− mice leads to chronic hepatic inflammation and failure of liver regeneration

Mohammed, F. F., Smookler, D. S., Taylor, S. E. M., Fingleton, B., Kassiri, Z., Sanchez, O. H., English, J. L., Matrisian, L. M., Au, B., Yeh, W., et al. (2004) · Nature Genetics · doi:10.1038/ng1413 · Cited by 284 · see citing works

Process Outgrowth of Oligodendrocytes Is Promoted by Interaction of Fyn Kinase with the Cytoskeletal Protein Tau

Klein, C., Krämer, E.-M., Cardine, A.-M., Schraven, B., Brandt, R., & Trotter, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00698.2002 · Cited by 250 · see citing works

Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer’s disease.

Lorenzl, S. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00004-4 · Cited by 243 · see citing works

Randomization and Monte Carlo methods in biology

(1992) · Choice Reviews Online · doi:10.5860/choice.29-3295 · Cited by 205 · see citing works

The effect of tau antisense oligonucleotides on neurite formation of cultured cerebellar macroneurons

Cáceres, A., Potrebic, S., & Kosik, K. S. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01515.1991 · Cited by 193 · see citing works

TIMP-3 INDUCES CELL DEATH BY STABILIZING TNF-α RECEPTORS ON THE SURFACE OF HUMAN COLON CARCINOMA CELLS

Smith, M. R., Kung, H., Durum, S. K., Colburn, N. H., & Sun, Y. (1997) · Cytokine · doi:10.1006/cyto.1997.0233 · Cited by 188 · see citing works

Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors

Ahonen, M., Poukkula, M., Baker, A. H., Kashiwagi, M., Nagase, H., Eriksson, J., & Kähäri, V. (2003) · Oncogene · doi:10.1038/sj.onc.1206292 · Cited by 173 · see citing works

PAK5, a New Brain-Specific Kinase, Promotes Neurite Outgrowth in N1E-115 Cells

Dan, C., Nath, N., Liberto, M., & Minden, A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.567-577.2002 · Cited by 163 · see citing works

Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases.

Lorenzl, S., Albers, D. S., LeWitt, P., Chirichigno, J. W., Hilgenberg, S. L., Cudkowicz, M., & Beal, M. (2003) · Journal of Neurological Sciences · doi:10.1016/s0022-510x(02)00398-2 · Cited by 162 · see citing works

Intracellular Clusterin Induces G2-M Phase Arrest and Cell Death in PC-3 Prostate Cancer Cells1

Scaltriti, M., Santamaría, A., Paciucci, R., & Bettuzzi, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0920 · Cited by 104 · see citing works

Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with α-synucleinopathies

Sasaki, K., Doh‐ura, K., Wakisaka, Y., & Iwaki, T. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0546-4 · Cited by 91 · see citing works

Developmental changes of tau protein and mRNA in cultured rat brain oligodendrocytes

Gorath, M., Stahnke, T., Mronga, T., Goldbaum, O., & Richter‐Landsberg, C. (2001) · Glia · doi:10.1002/glia.1098 · Cited by 81 · see citing works

A novel p21-activated kinase binds the actin and microtubule networks and induces microtubule stabilization

Cau, J., Faure, S., Comps, M., Delsert, C., & Morin, N. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200104123 · Cited by 78 · see citing works

Intracellular clusterin causes juxtanuclear aggregate formation and mitochondrial alteration

Debure, L., Vayssière, J., Rincheval, V., Loison, F., Dréan, Y. L., & Michel, D. (2003) · Journal of Cell Science · doi:10.1242/jcs.00619 · Cited by 77 · see citing works

Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience.

Hulette, C. M., Welsh-Bohmer, K. A., Crain, B. J., Szymanski, M. H., Sinclaire, N. O., & Roses, A. D. (1997) · PubMed · Cited by 67 · see citing works

Casein kinase II alteration precedes tau accumulation in tangle formation.

Masliah, E., Iimoto, D. S., Mallory, M. E., Albright, T., Hansen, L. A., & Saitoh, T. (1992) · PubMed Central · Cited by 67 · see citing works

Tissue Inhibitor of Metalloproteinase-3 Is Associated With Neuronal Death in Reperfusion Injury

Wallace, J. A., Alexander, S. M., Estrada, E. Y., Hines, C., Cunningham, L. A., & Rosenberg, G. A. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000040943.89393.c1 · Cited by 47 · see citing works

Casein kinase II is associated with neurofibrillary tangles but is not an intrinsic component of paired helical filaments

Baum, L., Masliah, E., Iimoto, D. S., Hansen, L. A., HALLIDAY, W. C., & Saitoh, T. (1992) · Brain Research · doi:10.1016/0006-8993(92)90121-o · Cited by 44 · see citing works

Inhibition of Neurofibrillary Degeneration: A Promising Approach to Alzheimers Disease and Other Tauopathies

Iqbal, K., & Grundke, I. (2004) · Current Drug Targets · doi:10.2174/1389450043345254 · Cited by 35 · see citing works

Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsy

Lorenzl, S., Albers, D. S., Chirichigno, J. W., Augood, S. J., & Beal, M. F. (2003) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.10.015 · Cited by 27 · see citing works

Clusterin shortens the incubation and alters the histopathology of bovine spongiform encephalopathy in mice

Kempster, S. L., Collins, M. E., Aronow, B. J., Simmons, M. M., Green, R. B., & Edington, N. (2004) · Neuroreport · doi:10.1097/01.wnr.0000134990.97051.22 · Cited by 21 · see citing works

Interleukin-1 induces tau phosphorylation and morphological changes in cultured human astrocytes

Tanji, K., Mori, F., Imaizumi, T., Yoshida, H., Satoh, K., & Wakabayashi, K. (2003) · Neuroreport · doi:10.1097/00001756-200303030-00023 · Cited by 19 · see citing works

Untitled work

Cole (2000) · doi:10.1002/1097-0029(20000815)50:4

Tau protein aggregation is associated with cellular senescence in the brain

Musi, N., Valentine, J. M., Sickora, K. R., Baeuerle, E., Thompson, C. S., Shen, Q., & Orr, M. E. (2018) · Aging Cell · doi:10.1111/acel.12840 · Cited by 595 · see citing works

Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons

Liang, W. S., Reiman, E. M., Valla, J., Dunckley, T., Beach, T. G., Grover, A., Niedzielko, T. L., Schneider, L. E., Mastroeni, D., Caselli, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709259105 · Cited by 585 · see citing works

<scp>A</scp>rizona <scp>S</scp>tudy of <scp>A</scp>ging and <scp>N</scp>eurodegenerative <scp>D</scp>isorders and <scp>B</scp>rain and <scp>B</scp>ody <scp>D</scp>onation <scp>P</scp>rogram

Beach, T. G., Adler, C. H., Sue, L. I., Serrano, G., Shill, H. A., Walker, D. G., Lue, L., Roher, A. E., Dugger, B. N., Maarouf, C., et al. (2015) · Neuropathology · doi:10.1111/neup.12189 · Cited by 460 · see citing works

Epigenetic changes in Alzheimer's disease: Decrements in DNA methylation

Mastroeni, D., Grover, A., Delvaux, E., Whiteside, C. M., Coleman, P. D., & Rogers, J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.12.005 · Cited by 386 · see citing works

Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies

Foster, E. M., Dangla-Valls, A., Lovestone, S., Ribe, E. M., & Buckley, N. J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00164 · Cited by 381 · see citing works

Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set

Liang, W. S., Dunckley, T., Beach, T. G., Grover, A., Mastroeni, D., Ramsey, K., Caselli, R. J., Kukull, W. A., McKeel, D., Morris, J. C., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00242.2007 · Cited by 309 · see citing works

A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer's disease

Xu, M., Zhang, D., Luo, R., Wu, Y., Zhou, H., Kong, L., Bi, R., & Yao, Y. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.08.012 · Cited by 294 · see citing works

Alzheimer disease, the two-hit hypothesis: An update

Zhu, X., Lee, H., Perry, G. L., & Smith, M. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.014 · Cited by 292 · see citing works

Genes and pathways underlying regional and cell type changes in Alzheimer’s disease

Miller, J. A., Woltjer, R. L., Goodenbour, J. M., Horvath, S., & Geschwind, D. H. (2013) · Genome Medicine · doi:10.1186/gm452 · Cited by 275 · see citing works

Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer’s disease

Otero-Garcia, M., Mahajani, S. U., Wakhloo, D., Tang, W., Xue, Y.-Q., Morabito, S., Pan, J., Oberhauser, J., Madira, A. E., Shakouri, T., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.06.021 · Cited by 262 · see citing works

Sodium Channel β Subunits: Emerging Targets in Channelopathies

O’Malley, H. A., & Isom, L. L. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071846 · Cited by 236 · see citing works

Gene expression profiling in human neurodegenerative disease

Cooper‐Knock, J., Kirby, J., Ferraiuolo, L., Heath, P. R., Rattray, M., & Shaw, P. J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.156 · Cited by 218 · see citing works

Selective Vulnerability of Neurons in Layer II of the Entorhinal Cortex during Aging and Alzheimer's Disease

Stranahan, A. M., & Mattson, M. P. (2010) · Neural Plasticity · doi:10.1155/2010/108190 · Cited by 198 · see citing works

Epigenetic changes in the progression of Alzheimer's disease

Bradley‐Whitman, M. A., & Lovell, M. A. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.08.005 · Cited by 193 · see citing works

Selective Neuronal Vulnerability in Alzheimer’s Disease: A Network-Based Analysis

Roussarie, J.-P., Yao, V., Rodriguez-Rodriguez, P., Oughtred, R., Rust, J., Plautz, Z., Kasturia, S., Albornoz, C., Wang, W., Schmidt, E. F., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.010 · Cited by 180 · see citing works

Profiling senescent cells in human brains reveals neurons with CDKN2D/p19 and tau neuropathology

Dehkordi, S. K., Walker, J., Sah, E., Bennett, E., Atrian, F., Frost, B., Woost, B., Bennett, R. E., Orr, T. C., Zhou, Y., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00142-3 · Cited by 169 · see citing works

Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease

Wes, P. D., Holtman, I. R., Boddeke, E. W. G. M., Möller, T., & Eggen, B. J. L. (2016) · Glia · doi:10.1002/glia.22866 · Cited by 167 · see citing works

The Influence of Alzheimer Disease Family History and Apolipoprotein E ε4 on Mesial Temporal Lobe Activation

Johnson, S. C., Schmitz, T. W., Trivedi, M. A., Ries, M. L., Torgerson, B. M., Carlsson, C. M., Asthana, S., Hermann, B. P., & Sager, M. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0959-06.2006 · Cited by 149 · see citing works

Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective

Rahman, M. R., Islam, T., Zaman, T., Shahjaman, M., Karim, M. R., Huq, F., Quinn, J. M. W., Holsinger, R. M. D., Gov, E., & Moni, M. A. (2020) · Genomics · doi:10.1016/j.ygeno.2019.07.018 · Cited by 136 · see citing works

Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease

Welch, G., & Tsai, L. (2022) · The EMBO Reports · doi:10.15252/embr.202154217 · Cited by 129 · see citing works

Alzheimer’s Patient Analysis Using Image and Gene Expression Data and Explainable-AI to Present Associated Genes

Kamal, M. S., Northcote, A., Chowdhury, L., Dey, N., Crespo, R. A. G., & Herrera‐Viedma, E. (2021) · IEEE Transactions on Instrumentation and Measurement · doi:10.1109/tim.2021.3107056 · Cited by 128 · see citing works

Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases

Ray, M., Ruan, J., & Zhang, W. (2008) · Genome Biology · doi:10.1186/gb-2008-9-10-r148 · Cited by 119 · see citing works

Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer’s disease

Rahman, M. R., Islam, T., Turanlı, B., Zaman, T., Faruquee, H. M., Rahman, M. M., Mollah, M. N. H., Nanda, R. K., Arğa, K. Y., Göv, E., et al. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.12.011 · Cited by 118 · see citing works

Evidence for an association between KIBRA and late-onset Alzheimer's disease

Corneveaux, J. J., Liang, W. S., Reiman, E. M., Webster, J., Myers, A., Zismann, V., Joshipura, K. D., Pearson, J. V., Hu‐Lince, D., Craig, D. W., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.014 · Cited by 112 · see citing works

Metalloproteinases and their tissue inhibitors in Alzheimer’s disease and other neurodegenerative disorders

Rivera, S., García‐González, L., Khrestchatisky, M., & Baranger, K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03178-2 · Cited by 112 · see citing works

Voltage-Gated Sodium Channel β Subunits and Their Related Diseases

Bouza, A. A., & Isom, L. L. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_48 · Cited by 111 · see citing works

Genetics, Transcriptomics, and Proteomics of Alzheimers Disease

Papassotiropoulos, A., Fountoulakis, M., Dunckley, T. L., Stephan, D. A., & Reiman, E. M. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0418 · Cited by 103 · see citing works

Cholinotrophic Molecular Substrates of Mild Cognitive Impairment in the Elderly

Mufson, E. J., Counts, S., Fahnestock, M. L., & Ginsberg, S. D. (2007) · Current Alzheimer Research · doi:10.2174/156720507781788855 · Cited by 100 · see citing works

Analysis of microRNA and Gene Expression Profiles in Alzheimer’s Disease: A Meta-Analysis Approach

Moradifard, S., Hoseinbeyki, M., Ganji, S. M., & Minuchehr, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-20959-0 · Cited by 103 · see citing works

Signal Transduction Cascades Associated with Oxidative Stress in Alzheimer's Disease

Petersen, R. B., Nunomura, A., Lee, H., Casadesús, G., Perry, G. L., Smith, M. A., & Zhu, X. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11202 · Cited by 99 · see citing works

A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease

Antonell, A., Lladó, A., Altirriba, J., Botta‐Orfila, T., Balasa, M., Fernández, M., Ferrer, I., Sánchez‐Valle, R., & Molinuevo, J. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.026 · Cited by 96 · see citing works

Concerted Perturbation Observed in a Hub Network in Alzheimer’s Disease

Liang, D., Han, G., Feng, X., Sun, J., Duan, Y., & Lei, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040498 · Cited by 93 · see citing works

c‐Jun phosphorylation in Alzheimer disease

Thakur, A., Wang, X., Siedlak, S. L., Perry, G. L., Smith, M. A., & Zhu, X. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21298 · Cited by 80 · see citing works

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease

Bryant, A. G., Hu, M., Carlyle, B. C., Arnold, S. E., Frosch, M. P., Das, S., Hyman, B. T., & Bennett, R. E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.575953 · Cited by 79 · see citing works

Transcriptomics in Alzheimer’s Disease: Aspects and Challenges

Bagyinszky, E., Giau, V. V., & An, S. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103517 · Cited by 75 · see citing works

MAPT Isoforms: Differential Transcriptional Profiles Related to 3R and 4R Splice Variants

Chen, S., Townsend, K. P., Goldberg, T. E., Davies, P., & Conejero‐Goldberg, C. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101155 · Cited by 75 · see citing works

Genetic study of multimodal imaging Alzheimer’s disease progression score implicates novel loci

Scelsi, M. A., Khan, R. R., Lorenzi, M., Christopher, L., Greicius, M. D., Schott, J. M., Ourselin, S., & Altmann, A. (2018) · Brain · doi:10.1093/brain/awy141 · Cited by 73 · see citing works

The Na+/H+ Exchanger NHE6 Modulates Endosomal pH to Control Processing of Amyloid Precursor Protein in a Cell Culture Model of Alzheimer Disease

Prasad, H., & Rao, R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.602219 · Cited by 72 · see citing works

CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer’s Disease

Initiative, A. D. N., Zhang, D., Li, J., Wu, H., Cui, Y. J., Bi, R., Zhou, H., Wang, H.-Z., Zhang, C., Wang, D., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.232 · Cited by 72 · see citing works

Dissecting Complex and Multifactorial Nature of Alzheimer’s Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective

Talwar, P., Sinha, J., Grover, S., Rawat, C., Kushwaha, S. S., Agarwal, R., Taneja, V., & Kukreti, R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9390-0 · Cited by 70 · see citing works

Understanding the pathogenesis of Alzheimer’s disease: will RNA‐Seq realize the promise of transcriptomics?

Sutherland, G. T., Janitz, M., & Kril, J. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07157.x · Cited by 67 · see citing works

Gene expression reveals overlap between normal aging and Alzheimer's disease genes

Avramopoulos, D., Szymanski, M., Wang, R., & Bassett, S. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.019 · Cited by 40 · see citing works

Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale

Ruffini, N., Klingenberg, S., Schweiger, S., & Gerber, S. (2020) · Cells · doi:10.3390/cells9122642 · Cited by 65 · see citing works

Genes associated with the progression of neurofibrillary tangles in Alzheimer’s disease

Miyashita, A., Hatsuta, H., Kikuchi, M., Nakaya, A., Saito, Y., Tsukie, T., Hara, N., Ogishima, S., Kitamura, N., Akazawa, K., et al. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.35 · Cited by 65 · see citing works

Postmortem Delay Has Minimal Effect on Brain RNA Integrity

Ervin, J. F., Heinzen, E. L., Cronin, K. D., Goldstein, D. B., Szymanski, M. H., Burke, J. R., Welsh-Bohmer, K. A., & Hulette, C. M. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31815c196a · Cited by 63 · see citing works

A computational framework for the prioritization of disease-gene candidates

Browne, F., Wang, H., & Zheng, H. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s9-s2 · Cited by 61 · see citing works

Differential protein expression in the hippocampi of resilient individuals identified by digital spatial profiling

Walker, J. M., Kazempour Dehkordi, S., Fracassi, A., Vanschoiack, A., Pavenko, A., Taglialatela, G., Woltjer, R., Richardson, T. E., Zare, H., & Orr, M. E. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01324-9 · Cited by 59 · see citing works

INTERSECTINg Pathways in Cell Biology

O’Bryan, J. P. (2010) · Science Signaling · doi:10.1126/scisignal.3152re10 · Cited by 58 · see citing works

Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype

Conejero‐Goldberg, C., Hyde, T. M., Chen, S., Dreses‐Werringloer, U., Herman, M. M., Kleinman, J. E., Davies, P., & Goldberg, T. E. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.57 · Cited by 53 · see citing works

Do Epigenetic Pathways Initiate Late Onset Alzheimer Disease (LOAD): Towards a New Paradigm

Bihaqi, S. W., Schumacher, A., Maloney, B., Lahiri, D. K., & Zawia, N. H. (2012) · Current Alzheimer Research · doi:10.2174/156720512800617982 · Cited by 52 · see citing works

Down-Regulation of Energy Metabolism in Alzheimer's Disease is a Protective Response of Neurons to the Microenvironment

Sun, J., Feng, X., Liang, D., Duan, Y., & Lei, H. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111313 · Cited by 49 · see citing works

Amyloid-β toxicity modulates tau phosphorylation through the PAX6 signalling pathway

Zhang, Y., Zhang, Y., Aman, Y., Ng, C. T., Chau, W. H., Zhang, Z., Yue, M., Böhm, C., Jia, Y., Li, S., et al. (2021) · Brain · doi:10.1093/brain/awab134 · Cited by 47 · see citing works

Dissection of functional lncRNAs in Alzheimer's disease by construction and analysis of lncRNA–mRNA networks based on competitive endogenous RNAs

Wang, L., Chen, X., He, D.-D., Li, Y., & Fu, J. X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.143 · Cited by 48 · see citing works

Emerging Roles for Intersectin (ITSN) in Regulating Signaling and Disease Pathways

Hunter, M. P., Russo, A., & O’Bryan, J. P. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14047829 · Cited by 47 · see citing works

The Diverse Roles of TIMP-3: Insights into Degenerative Diseases of the Senescent Retina and Brain

Dewing, J. M., Carare, R. O., Lotery, A. J., & Ratnayaka, J. A. (2019) · Cells · doi:10.3390/cells9010039 · Cited by 46 · see citing works

Intersectin scaffold proteins and their role in cell signaling and endocytosis

Herrero-Garcia, E., & O’Bryan, J. P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.10.005 · Cited by 45 · see citing works

AlzBase: An Integrative Database for Gene Dysregulation in Alzheimer’s Disease

Bai, Z., Han, G., Xie, B., Wang, J., Song, F., Peng, X., & Lei, H. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9011-3 · Cited by 44 · see citing works

Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease.

Mufson, E., Counts, S., Che, S.-L., & Ginsberg, S. D. (2006) · Progress in Brain Research · doi:10.1016/s0079-6123(06)58010-0 · Cited by 42 · see citing works

PLD3 in Alzheimer’s Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses

Zhang, D., Fan, Y., Wang, D., Bi, R., Zhang, C., Fang, Y., & Yao, Y. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9353-5 · Cited by 39 · see citing works

Linking Brain Imaging and Genomics in the Study of Alzheimer's Disease and Aging

Reiman, E. M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1379.011 · Cited by 39 · see citing works

Dissecting gene expression at the blood-brain barrier

Huntley, M. A., Bien‐Ly, N., Daneman, R., & Watts, R. J. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00355 · Cited by 38 · see citing works

Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease

Tiernan, C. T., Ginsberg, S. D., Guillozet-Bongaarts, A. L., Ward, S., He, B., Kanaan, N. M., Mufson, E. J., Binder, L. I., & Counts, S. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.031 · Cited by 37 · see citing works

Intersectin 1 contributes to phenotypes in vivo

Hunter, M. P., Nelson, M., Kurzer, M., Wang, X., Kryscio, R. J., Head, E., Pinna, G., & O’Bryan, J. P. (2011) · Neuroreport · doi:10.1097/wnr.0b013e32834ae348 · Cited by 35 · see citing works

Discovering Biomarkers and Pathways Shared by Alzheimer’s Disease and Ischemic Stroke to Identify Novel Therapeutic Targets

Rahman, M. R., Islam, T., Shahjaman, M., Zaman, T., Faruquee, H. M., Jamal, M. A. H. M., Huq, F., Quinn, J. M. W., & Moni, M. A. (2019) · Medicina · doi:10.3390/medicina55050191 · Cited by 35 · see citing works

Aβ treatment and P301L tau expression in an Alzheimer's disease tissue culture model act synergistically to promote aberrant cell cycle re‐entry

Hoerndli, F. J., Pelech, S., Papassotiropoulos, A., & Götz, J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05618.x · Cited by 34 · see citing works

Translational gene mapping of cognitive decline

Wilmot, B., McWeeney, S. K., Nixon, R. R., Montine, T. J., Laut, J., Harrington, C. A., Kaye, J. A., & Kramer, P. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.11.008 · Cited by 35 · see citing works

Network-based identification of genetic factors in ageing, lifestyle and type 2 diabetes that influence to the progression of Alzheimer's disease

Chowdhury, U. N., Ahmad, S., Islam, M. B., Huq, F., Quinn, J. M. W., & Moni, M. A. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100309 · Cited by 34 · see citing works

Outside-in induction of the IFITM3 trafficking system by infections, including SARS-CoV-2, in the pathobiology of Alzheimer’s disease

Vavougios, G. D., Nday, C. M., Pelidou, S., Gourgoulianis, K. I., Stamoulis, G. I., Doskas, T. K., & Zarogiannis, S. G. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100243 · Cited by 32 · see citing works

Gene Expression Profiling of Peripheral Blood Leukocytes Shows Consistent Longitudinal Downregulation of TOMM40 and Upregulation of KIR2DL5A, PLOD1, and SLC2A8 Among Fast Progressors in Early Alzheimer's Disease

Chong, M. S., Goh, L. K., Lim, W. S., Chan, M., Tay, L. B. G., Chen, G., Feng, L., Ng, T. P., Tan, C. H., & Lee, T.-S. W. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121621 · Cited by 32 · see citing works

Microarray Analysis of Differential Gene Expression in Alzheimer’s Disease Identifies Potential Biomarkers with Diagnostic Value

Liu, L., Wu, Q. J., Zhong, W., Chen, Y., Zhang, W., Ren, H., Sun, L., & Sun, J. (2020) · Medical Science Monitor · doi:10.12659/msm.919249 · Cited by 31 · see citing works

Evidence of the Cellular Senescence Stress Response in Mitotically Active Brain Cells—Implications for Cancer and Neurodegeneration

Gillispie, G., Sah, E., Krishnamurthy, S., Ahmidouch, M. Y., Zhang, B., & Orr, M. E. (2021) · Life · doi:10.3390/life11020153 · Cited by 26 · see citing works

HYPK coordinates degradation of polyneddylated proteins by autophagy

Ghosh, D. K., & Ranjan, A. (2021) · Autophagy · doi:10.1080/15548627.2021.1997053 · Cited by 31 · see citing works

Selective neuronal vulnerability in Alzheimer’s disease: a network-based analysisPreprint

Roussarie, J.-P., Yao, V., Plautz, Z., Kasturia, S. E., Albornoz, C. A., Schmidt, E. F., Brichta, L., Barnea-Cramer, A. O., Heintz, N., Hof, P. R., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/499897 · Cited by 31 · see citing works

Identifying Effective Feature Selection Methods for Alzheimer’s Disease Biomarker Gene Detection Using Machine Learning

Alshamlan, H., Omar, S., Aljurayyad, R., & Alabduljabbar, R. (2023) · Diagnostics · doi:10.3390/diagnostics13101771 · Cited by 30 · see citing works

A Computational Framework for Genome-wide Characterization of the Human Disease Landscape

Lee, Y.-S., Krishnan, A., Oughtred, R., Rust, J., Chang, C., Ryu, J., Kristensen, V. N., Dolinski, K. J., Theesfeld, C. L., & Troyanskaya, O. G. (2019) · Cell Systems · doi:10.1016/j.cels.2018.12.010 · Cited by 28 · see citing works

Altered mitochondrial microenvironment at the spotlight of musculoskeletal aging and Alzheimer’s disease

Giannos, P., Prokopidis, K., Raleigh, S. M., Kelaiditi, E., & Hill, M. W. (2022) · Scientific Reports · doi:10.1038/s41598-022-15578-9 · Cited by 28 · see citing works

Downregulation of TOMM40 expression in the blood of Alzheimer disease subjects compared with matched controls

Lee, T.-S. W., Goh, L. K., Chong, M. S., Chua, S. M., Chen, G. B., Feng, L., Lim, W. S., Chan, M., Ng, T. P., & Krishnan, K. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.03.006 · Cited by 27 · see citing works

Machine learning techniques to discover genes with potential prognosis role in Alzheimer’s disease using different biological sources

Martínez-Ballesteros, M., García-Heredia, J. M., Nepomuceno-Chamorro, I. A., & Riquelme, J. C. (2016) · Information Fusion · doi:10.1016/j.inffus.2016.11.005 · Cited by 26 · see citing works

Comprehensive analysis of the lncRNA-associated ceRNA network identifies neuroinflammation biomarkers for Alzheimer's disease

Zhou, Y., Xu, Z., Yu, Y., Cao, J., Qiao, Y., Qiao, H., & Suo, G. (2019) · Molecular Omics · doi:10.1039/c9mo00129h · Cited by 26 · see citing works

Clusterin is a Potential Therapeutic Target in Alzheimer’s Disease

Palihati, N., Tang, Y., Yin, Y., Yu, D., Liu, G., Quan, Z., Ni, J., Yan, Y., & Qing, H. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03801-1 · Cited by 25 · see citing works

The Prevalence of Alzheimer's Disease in China: A Systematic Review and Meta-analysis.

Li, K., Wei, S., Liu, Z., Li, H., Lin, J., Tan, S., Mai, Y., Peng, W., Mai, H., Hou, Q., et al. (2018) · Europe PMC (PubMed Central) · Cited by 24 · see citing works

Focusing on cellular biomarkers: The endo-lysosomal pathway in Down syndrome.

Botté, A., & Potier, M. (2020) · Progress in Brain Research · doi:10.1016/bs.pbr.2019.10.002 · Cited by 20 · see citing works

Metabolic regulation of aging and age-related disease

Hamrick, M. W., & Stranahan, A. M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101175 · Cited by 26 · see citing works

Is Seladin-1 Really a Selective Alzheimer's Disease Indicator?

Sharpe, L. J., Wong, J., Garner, B., Halliday, G. M., & Brown, A. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111955 · Cited by 24 · see citing works

Common molecular biomarker signatures in blood and brain of Alzheimer’s diseasePreprint

Rahman, M. R., Islam, T., Shahjaman, M., Quinn, J. M. W., Holsinger, R. M. D., & Moni, M. A. (2018) · bioRxiv · doi:10.1101/482828 · Cited by 17 · see citing works

Network Topology Analysis of Post-Mortem Brain Microarrays Identifies More Alzheimer’s Related Genes and MicroRNAs and Points to Novel Routes for Fighting with the Disease

Chandrasekaran, S., & Bonchev, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0144052 · Cited by 23 · see citing works

The Construction of Common and Specific Significance Subnetworks of Alzheimer’s Disease from Multiple Brain Regions

Kong, W., Mou, X., Zhang, N., Zeng, W., Li, S., & Yang, Y. (2015) · BioMed Research International · doi:10.1155/2015/394260 · Cited by 23 · see citing works

Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer’s Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks

Wruck, W., Schröter, F., & Adjaye, J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150733 · Cited by 22 · see citing works

A Selection of Important Genes and Their Correlated Behavior in Alzheimer’s Disease

Cruz-Rivera, Y. E., Pérez‐Morales, J., Santiago, Y. M., Gonzalez, V., Morales, L., Cabrera‐Ríos, M., & Isaza, C. E. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170799 · Cited by 22 · see citing works

An integrated approach to unravel a putative crosstalk network in Alzheimer’s disease and Parkinson’s disease

Bisht, I., Ambasta, R. K., & Kumar, P. (2020) · Neuropeptides · doi:10.1016/j.npep.2020.102078 · Cited by 20 · see citing works

Revelation of Pivotal Genes Pertinent to Alzheimer’s Pathogenesis: A Methodical Evaluation of 32 GEO Datasets

Sree, G. N. S. H., Rajalekshmi, S. G., & Burri, R. R. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01919-2 · Cited by 18 · see citing works

Sex-specific associations of matrix metalloproteinases in Alzheimer’s disease

Aksnes, M., Edwin, T. H., Saltvedt, I. T., Eldholm, R. S., Chaudhry, F. A., Halaas, N. B., Myrstad, M., Watne, L. O., & Knapskog, A. (2023) · Biology of Sex Differences · doi:10.1186/s13293-023-00514-x · Cited by 20 · see citing works

Hippocampal DHCR24 down regulation in a rat model of streptozotocin-induced cognitive decline

Hosseinzadeh, S., Zahmatkesh, M., Heidari, M., Hassanzadeh, G., Karimian, M., Sarrafnejad, A., & Zarrindast, M. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.12.039 · Cited by 20 · see citing works

Identification of biomarkers and pathways to identify novel therapeutic targets in Alzheimer’s disease: Insights from a systems biomedicine perspectivePreprint

Rahman, M. R., Islam, T., Zaman, T., Shahjaman, M., Karim, M. R., Huq, F., Quinn, J. M. W., Holsinger, R. M. D., & Moni, M. A. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/481879 · Cited by 19 · see citing works

Tooth Loss Suppresses Hippocampal Neurogenesis and Leads to Cognitive Dysfunction in Juvenile Sprague–Dawley Rats

Hu, J., Wang, X., Kong, W., & Jiang, Q. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.839622 · Cited by 18 · see citing works

Matrix metalloproteinases are associated with brain atrophy in cognitively unimpaired individuals.

Aksnes, M., Capogna, E., Vidal-Piñeiro, D., Chaudhry, F., Myrstad, M., Idland, A., Halaas, N., Dakhil, S., Blennow, K., Zetterberg, H., et al. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.05.012 · Cited by 16 · see citing works

Minding the Gap: Exploring Neuroinflammatory and Microglial Sex Differences in Alzheimer’s Disease

Reed-Geaghan, E. G., & Keller-Norrell, P. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417377 · Cited by 19 · see citing works

Transcriptional signatures of hippocampal tau pathology in primary age-related tauopathy and Alzheimer’s disease

Stein-O’Brien, G., Palaganas, R. G., Meyer, E. M., Redding‐Ochoa, J., Pletniková, O., Guo, H., Bell, W. R., Troncoso, J. C., Huganir, R. L., & Morris, M. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115422 · Cited by 18 · see citing works

P2‐014: GENES ASSOCIATED WITH THE PROGRESSION OF NEUROFIBRILLARY TANGLES IN ALZHEIMER'S DISEASE BRAINS

Miyashita, A., Kuwano, R., Hatsuta, H., Kikuchi, M., Nakaya, A., Saito, Y., Tsukie, T., Hara, N., Ogishima, S., Kakita, A., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.687

Altered apolipoprotein D expression in the brain of patients with Alzheimer disease

Belloir, B., Kövari, E., Surini, M., & Savioz, A. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1054 · Cited by 70 · see citing works

[18F]Fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies

Antoine, J.-C. G., Cinotti, L., Tilikete, C., Bouhour, F., Camdessanch�, J. P., Confavreux, C., Vighetto, A., Renault‐Mannel, V., Michel, D., & Honnorat, J. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200007)48:1 · Cited by 86 · see citing works

Genes associated with the progression of neurofibrillary tangles in Alzheimer’s disease

Miyashita, A., Hatsuta, H., Kikuchi, M., Nakaya, A., Saito, Y., Tsukie, T., Hara, N., Ogishima, S., Kitamura, N., Akazawa, K., et al. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.35 · Cited by 65 · see citing works

Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set

Liang, W. S., Dunckley, T., Beach, T. G., Grover, A., Mastroeni, D., Ramsey, K., Caselli, R. J., Kukull, W. A., McKeel, D., Morris, J. C., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00242.2007 · Cited by 309 · see citing works